Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-082535

Chairman & CEO bought 200 shares at $14.33 ($2,866)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-07-19 Purchase : show line 1 in the form +200 $14.33 $2,866 3,231,559 D
Open-market purchases · 200 sh · avg $14.33 · $2,866
Loading xslF345X05/tm2321693-1_4seq1.xml…